| Characteristics . | Hospitalized (N = 7200) . | Not hospitalized (N = 10 913) . | P-valuea . | Cardiovascular hospitalized (N = 2920) . |
|---|---|---|---|---|
| Age (years) (SD) | 72.5 (8.4) | 70.8 (8.8) | <0.0001 | 71.8 (8.7) |
| BMI (kg/m2), N (%) | <0.0001 | |||
| <25 | 1801 (25.0) | 2896 (26.6) | 675 (23.1) | |
| 25–30 | 2757 (38.3) | 4354 (40.0) | 1153 (39.5) | |
| 30–35 | 1657 (23.0) | 2381 (21.9) | 689 (23.6) | |
| ≥35 | 976 (13.6) | 1265 (11.6) | 400 (13.7) | |
| Male gender, N (%) | 4517 (62.7) | 6997 (64.1) | 0.06 | 1804 (61.8) |
| Type of atrial fibrillation, N (%) | <0.0001 | |||
| Paroxysmal | 2602 (36.1) | 3341 (30.6) | 1173 (40.2) | |
| Persistent | 2271 (31.5) | 3518 (32.3) | 907 (31.1) | |
| Permanent | 2326 (32.3) | 4049 (37.1) | 840 (28.8) | |
| CHADS2 score, N (%) | <0.0001 | |||
| 0 or 1 | 1966 (27.3) | 3817 (35.0) | 754 (25.8) | |
| 2 | 2549 (35.4) | 3904 (35.8) | 1059 (36.3) | |
| ≥3 | 2685 (37.3) | 3191 (29.2) | 1107 (37.9) | |
| Previous stroke or TIA or systemic embolic event, N (%) | 1636 (22.7) | 2317 (21.2) | 0.02 | 646 (22.1) |
| Prior myocardial infarction or CAD, N (%) | 2673 (37.1) | 2977 (27.3) | <0.0001 | 1218 (41.7) |
| History of heart failure, N (%) | 2494 (34.6) | 3299 (30.2) | <0.0001 | 1137 (38.9) |
| Diabetes mellitus, N (%) | 1940 (26.9) | 2281 (20.9) | <0.0001 | 832 (28.5) |
| Hypertension, N (%) | 5763 (80.0) | 8520 (78.1) | 0.001 | 2363 (80.9) |
| Valvular heart disease, N (%) | 1728 (24.0) | 2216 (20.3) | <0.0001 | 719 (24.6) |
| CrCl ≤50 mL/min, N (%) | 1658 (23.2) | 1896 (17.5) | <0.0001 | 654 (22.6) |
| Cancer at baseline, N (%) | 889 (12.3) | 996 (9.1) | <0.0001 | 348 (11.9) |
| Characteristics . | Hospitalized (N = 7200) . | Not hospitalized (N = 10 913) . | P-valuea . | Cardiovascular hospitalized (N = 2920) . |
|---|---|---|---|---|
| Age (years) (SD) | 72.5 (8.4) | 70.8 (8.8) | <0.0001 | 71.8 (8.7) |
| BMI (kg/m2), N (%) | <0.0001 | |||
| <25 | 1801 (25.0) | 2896 (26.6) | 675 (23.1) | |
| 25–30 | 2757 (38.3) | 4354 (40.0) | 1153 (39.5) | |
| 30–35 | 1657 (23.0) | 2381 (21.9) | 689 (23.6) | |
| ≥35 | 976 (13.6) | 1265 (11.6) | 400 (13.7) | |
| Male gender, N (%) | 4517 (62.7) | 6997 (64.1) | 0.06 | 1804 (61.8) |
| Type of atrial fibrillation, N (%) | <0.0001 | |||
| Paroxysmal | 2602 (36.1) | 3341 (30.6) | 1173 (40.2) | |
| Persistent | 2271 (31.5) | 3518 (32.3) | 907 (31.1) | |
| Permanent | 2326 (32.3) | 4049 (37.1) | 840 (28.8) | |
| CHADS2 score, N (%) | <0.0001 | |||
| 0 or 1 | 1966 (27.3) | 3817 (35.0) | 754 (25.8) | |
| 2 | 2549 (35.4) | 3904 (35.8) | 1059 (36.3) | |
| ≥3 | 2685 (37.3) | 3191 (29.2) | 1107 (37.9) | |
| Previous stroke or TIA or systemic embolic event, N (%) | 1636 (22.7) | 2317 (21.2) | 0.02 | 646 (22.1) |
| Prior myocardial infarction or CAD, N (%) | 2673 (37.1) | 2977 (27.3) | <0.0001 | 1218 (41.7) |
| History of heart failure, N (%) | 2494 (34.6) | 3299 (30.2) | <0.0001 | 1137 (38.9) |
| Diabetes mellitus, N (%) | 1940 (26.9) | 2281 (20.9) | <0.0001 | 832 (28.5) |
| Hypertension, N (%) | 5763 (80.0) | 8520 (78.1) | 0.001 | 2363 (80.9) |
| Valvular heart disease, N (%) | 1728 (24.0) | 2216 (20.3) | <0.0001 | 719 (24.6) |
| CrCl ≤50 mL/min, N (%) | 1658 (23.2) | 1896 (17.5) | <0.0001 | 654 (22.6) |
| Cancer at baseline, N (%) | 889 (12.3) | 996 (9.1) | <0.0001 | 348 (11.9) |
Missing data: CHADS2 score data missing in one patient and CrCl <50 data missing in 162 patients.
BMI, body mass index; CAD, coronary artery disease; CrCl, creatinine clearance; SD, standard deviation; TIA, transient ischaemic attack.
P-value (from Fisher’s exact test for binary data, t-test for continuous data, or χ2 test for categorical data) reported compares patients hospitalized compared with non-hospitalized patients.
| Characteristics . | Hospitalized (N = 7200) . | Not hospitalized (N = 10 913) . | P-valuea . | Cardiovascular hospitalized (N = 2920) . |
|---|---|---|---|---|
| Age (years) (SD) | 72.5 (8.4) | 70.8 (8.8) | <0.0001 | 71.8 (8.7) |
| BMI (kg/m2), N (%) | <0.0001 | |||
| <25 | 1801 (25.0) | 2896 (26.6) | 675 (23.1) | |
| 25–30 | 2757 (38.3) | 4354 (40.0) | 1153 (39.5) | |
| 30–35 | 1657 (23.0) | 2381 (21.9) | 689 (23.6) | |
| ≥35 | 976 (13.6) | 1265 (11.6) | 400 (13.7) | |
| Male gender, N (%) | 4517 (62.7) | 6997 (64.1) | 0.06 | 1804 (61.8) |
| Type of atrial fibrillation, N (%) | <0.0001 | |||
| Paroxysmal | 2602 (36.1) | 3341 (30.6) | 1173 (40.2) | |
| Persistent | 2271 (31.5) | 3518 (32.3) | 907 (31.1) | |
| Permanent | 2326 (32.3) | 4049 (37.1) | 840 (28.8) | |
| CHADS2 score, N (%) | <0.0001 | |||
| 0 or 1 | 1966 (27.3) | 3817 (35.0) | 754 (25.8) | |
| 2 | 2549 (35.4) | 3904 (35.8) | 1059 (36.3) | |
| ≥3 | 2685 (37.3) | 3191 (29.2) | 1107 (37.9) | |
| Previous stroke or TIA or systemic embolic event, N (%) | 1636 (22.7) | 2317 (21.2) | 0.02 | 646 (22.1) |
| Prior myocardial infarction or CAD, N (%) | 2673 (37.1) | 2977 (27.3) | <0.0001 | 1218 (41.7) |
| History of heart failure, N (%) | 2494 (34.6) | 3299 (30.2) | <0.0001 | 1137 (38.9) |
| Diabetes mellitus, N (%) | 1940 (26.9) | 2281 (20.9) | <0.0001 | 832 (28.5) |
| Hypertension, N (%) | 5763 (80.0) | 8520 (78.1) | 0.001 | 2363 (80.9) |
| Valvular heart disease, N (%) | 1728 (24.0) | 2216 (20.3) | <0.0001 | 719 (24.6) |
| CrCl ≤50 mL/min, N (%) | 1658 (23.2) | 1896 (17.5) | <0.0001 | 654 (22.6) |
| Cancer at baseline, N (%) | 889 (12.3) | 996 (9.1) | <0.0001 | 348 (11.9) |
| Characteristics . | Hospitalized (N = 7200) . | Not hospitalized (N = 10 913) . | P-valuea . | Cardiovascular hospitalized (N = 2920) . |
|---|---|---|---|---|
| Age (years) (SD) | 72.5 (8.4) | 70.8 (8.8) | <0.0001 | 71.8 (8.7) |
| BMI (kg/m2), N (%) | <0.0001 | |||
| <25 | 1801 (25.0) | 2896 (26.6) | 675 (23.1) | |
| 25–30 | 2757 (38.3) | 4354 (40.0) | 1153 (39.5) | |
| 30–35 | 1657 (23.0) | 2381 (21.9) | 689 (23.6) | |
| ≥35 | 976 (13.6) | 1265 (11.6) | 400 (13.7) | |
| Male gender, N (%) | 4517 (62.7) | 6997 (64.1) | 0.06 | 1804 (61.8) |
| Type of atrial fibrillation, N (%) | <0.0001 | |||
| Paroxysmal | 2602 (36.1) | 3341 (30.6) | 1173 (40.2) | |
| Persistent | 2271 (31.5) | 3518 (32.3) | 907 (31.1) | |
| Permanent | 2326 (32.3) | 4049 (37.1) | 840 (28.8) | |
| CHADS2 score, N (%) | <0.0001 | |||
| 0 or 1 | 1966 (27.3) | 3817 (35.0) | 754 (25.8) | |
| 2 | 2549 (35.4) | 3904 (35.8) | 1059 (36.3) | |
| ≥3 | 2685 (37.3) | 3191 (29.2) | 1107 (37.9) | |
| Previous stroke or TIA or systemic embolic event, N (%) | 1636 (22.7) | 2317 (21.2) | 0.02 | 646 (22.1) |
| Prior myocardial infarction or CAD, N (%) | 2673 (37.1) | 2977 (27.3) | <0.0001 | 1218 (41.7) |
| History of heart failure, N (%) | 2494 (34.6) | 3299 (30.2) | <0.0001 | 1137 (38.9) |
| Diabetes mellitus, N (%) | 1940 (26.9) | 2281 (20.9) | <0.0001 | 832 (28.5) |
| Hypertension, N (%) | 5763 (80.0) | 8520 (78.1) | 0.001 | 2363 (80.9) |
| Valvular heart disease, N (%) | 1728 (24.0) | 2216 (20.3) | <0.0001 | 719 (24.6) |
| CrCl ≤50 mL/min, N (%) | 1658 (23.2) | 1896 (17.5) | <0.0001 | 654 (22.6) |
| Cancer at baseline, N (%) | 889 (12.3) | 996 (9.1) | <0.0001 | 348 (11.9) |
Missing data: CHADS2 score data missing in one patient and CrCl <50 data missing in 162 patients.
BMI, body mass index; CAD, coronary artery disease; CrCl, creatinine clearance; SD, standard deviation; TIA, transient ischaemic attack.
P-value (from Fisher’s exact test for binary data, t-test for continuous data, or χ2 test for categorical data) reported compares patients hospitalized compared with non-hospitalized patients.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
